DK2579042T3 - Fremgangsmåde til at påvise Aß-specifikke antistoffer i en biologisk prøve - Google Patents

Fremgangsmåde til at påvise Aß-specifikke antistoffer i en biologisk prøve

Info

Publication number
DK2579042T3
DK2579042T3 DK11183842.1T DK11183842T DK2579042T3 DK 2579042 T3 DK2579042 T3 DK 2579042T3 DK 11183842 T DK11183842 T DK 11183842T DK 2579042 T3 DK2579042 T3 DK 2579042T3
Authority
DK
Denmark
Prior art keywords
detecting
biological sample
specific antibodies
antibodies
specific
Prior art date
Application number
DK11183842.1T
Other languages
English (en)
Inventor
Martina Lutterova
Günther Staffler
Andreas Mairhofer
Achim Schneeberger
Walter Schmidt
Frank Mattner
Original Assignee
Affiris Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Affiris Ag filed Critical Affiris Ag
Application granted granted Critical
Publication of DK2579042T3 publication Critical patent/DK2579042T3/da

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/566—Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701—Details
    • G01N2333/4709—Amyloid plaque core protein
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • G01N2800/2814—Dementia; Cognitive disorders
    • G01N2800/2821—Alzheimer

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Rehabilitation Therapy (AREA)
  • Rheumatology (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
  • Sampling And Sample Adjustment (AREA)
DK11183842.1T 2011-10-04 2011-10-04 Fremgangsmåde til at påvise Aß-specifikke antistoffer i en biologisk prøve DK2579042T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP11183842.1A EP2579042B1 (en) 2011-10-04 2011-10-04 Method for detecting Aß-specific antibodies in a biological sample

Publications (1)

Publication Number Publication Date
DK2579042T3 true DK2579042T3 (da) 2014-07-21

Family

ID=46888451

Family Applications (2)

Application Number Title Priority Date Filing Date
DK11183842.1T DK2579042T3 (da) 2011-10-04 2011-10-04 Fremgangsmåde til at påvise Aß-specifikke antistoffer i en biologisk prøve
DK12761989.8T DK2764367T3 (da) 2011-10-04 2012-09-20 Fremgangsmåde til diagnostisering af alzheimer s sygdom (ad)

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK12761989.8T DK2764367T3 (da) 2011-10-04 2012-09-20 Fremgangsmåde til diagnostisering af alzheimer s sygdom (ad)

Country Status (23)

Country Link
US (2) US9625459B2 (da)
EP (3) EP2579042B1 (da)
JP (2) JP6162127B2 (da)
KR (2) KR20140073568A (da)
CN (2) CN103842824A (da)
AR (1) AR088108A1 (da)
AU (2) AU2012320766B2 (da)
BR (2) BR112014008088A2 (da)
CA (2) CA2850843A1 (da)
CY (1) CY1115624T1 (da)
DK (2) DK2579042T3 (da)
ES (2) ES2496341T3 (da)
HR (1) HRP20140937T1 (da)
IL (2) IL231057A0 (da)
MX (2) MX2014003984A (da)
PL (2) PL2579042T3 (da)
PT (1) PT2579042E (da)
RS (1) RS53496B1 (da)
RU (2) RU2014117671A (da)
SG (2) SG11201400223SA (da)
SI (1) SI2579042T1 (da)
SM (1) SMT201400145B (da)
WO (2) WO2013050249A1 (da)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2787349A1 (en) 2013-04-03 2014-10-08 Affiris AG Method for detecting proteinopathy-specific antibodies in a biological sample
EP2787347A1 (en) * 2013-04-03 2014-10-08 Affiris AG Method for detecting Aß-specific antibodies in a biological sample
WO2015165961A1 (en) 2014-04-29 2015-11-05 Affiris Ag Treatment and prevention of alzheimer's disease (ad)
KR101658620B1 (ko) * 2014-12-02 2016-09-23 주식회사 피플바이오 응집형-형성 폴리펩타이드의 응집형을 검출하는 방법
KR20170108203A (ko) * 2016-03-16 2017-09-27 주식회사 피플바이오 응집형-형성 폴리펩타이드의 응집형을 검출하는 방법
KR101871895B1 (ko) * 2016-04-20 2018-06-28 한국과학기술연구원 응집 단백질의 고감도 광 산화 증폭 면역 분석을 통한 체액기반의 퇴행성 신경질환 진단 방법
EP3242134A1 (en) * 2016-05-04 2017-11-08 Euroimmun Medizinische Labordiagnostika AG Assay for the diagnosis of a neurological disease
KR101989383B1 (ko) * 2017-04-04 2019-06-14 조선대학교산학협력단 알츠하이머성 치매의 조기진단을 위한 펩타이드 프로브
KR102108171B1 (ko) * 2018-08-27 2020-05-08 광주과학기술원 알츠하이머성 치매 진단용 펩타이드 바이오마커
WO2020045962A1 (ko) * 2018-08-27 2020-03-05 광주과학기술원 알츠하이머성 치매 진단용 펩타이드 바이오마커
CN113063949B (zh) * 2021-03-23 2024-11-15 中国医学科学院输血研究所 一种血浆中特异性IgM抗体的定量测定方法
CN113075398A (zh) * 2021-03-23 2021-07-06 中国医学科学院输血研究所 一种血浆中特异性IgG抗体的定量测定方法

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5262332A (en) * 1989-04-05 1993-11-16 Brigham And Women's Hospital Diagnostic method for Alzheimer's disease: examination of non-neural tissue
WO1996012544A1 (en) 1994-10-19 1996-05-02 The General Hospital Corporation A DIAGNOSTIC ASSAY FOR ALZHEIMER'S DISEASE: ASSESSMENT OF Aβ ABNORMALITIES
US7427392B1 (en) 1994-11-14 2008-09-23 Elan Pharmaceuticals, Inc. Methods for aiding in the diagnosis of alzheimer's disease by measuring amyloid-β peptide (x-≧41) and tau
TWI239847B (en) 1997-12-02 2005-09-21 Elan Pharm Inc N-terminal fragment of Abeta peptide and an adjuvant for preventing and treating amyloidogenic disease
UA81216C2 (en) 1999-06-01 2007-12-25 Prevention and treatment of amyloid disease
CN102766210B (zh) 1999-08-24 2015-07-08 E.R.施贵宝&圣斯有限责任公司 人ctla-4抗体及其应用
AT413945B (de) 2003-01-14 2006-07-15 Mattner Frank Dr Impfstoff für die alzheimer-krankheit
WO2004074837A1 (en) * 2003-02-24 2004-09-02 Digitalbiotech Co., Ltd. Method for measuring the level of anti-beta-amyloid antibody in body fluids and diagnostic kit for alzheimer’s disease using same
AT413336B (de) 2003-09-12 2006-02-15 Mattner Frank Dr Apherese-vorrichtung
AT500483B1 (de) 2004-07-13 2006-01-15 Mattner Frank Dr Set zur vorbeugung oder behandlung der alzheimer'schen erkrankung
AT413946B (de) 2004-07-13 2006-07-15 Mattner Frank Dr Impfstoff gegen die alzheimer-krankheit
DE102005006217B4 (de) * 2005-02-07 2007-08-16 Universitätsklinikum Hamburg-Eppendorf Diagnose von allergischen Erkrankungen und/oder atopischen Erkrankungen durch Nachweis von Autoantikörpern gegen CD28 in humanem Serum
JP4937143B2 (ja) * 2005-03-05 2012-05-23 アボット ゲーエムベーハー ウント カンパニー カーゲー 非拡散性球状Aβ(X−38..43)オリゴマー構造エピトープに対して特異性を有する自己抗体を検出する方法
TW200726774A (en) * 2005-06-30 2007-07-16 Merck & Co Inc Composition and method for producing stable amyloid beta oligomers
RU2444356C2 (ru) 2005-07-08 2012-03-10 Мартек Байосайенсиз Корпорейшн Полиненасыщенные жирные кислоты для лечения деменции и состояний, связанных с преддеменцией
MX2008007477A (es) * 2005-12-12 2008-09-03 Ac Immune Sa Anticuerpos monoclonales especificos 1-42 beta con propiedades terapeuticas.
AU2008204335B2 (en) * 2007-01-11 2013-06-13 Michael Bacher Diagnosis and treatment of Alzheimer's and other neurodementing diseases
WO2009051599A1 (en) * 2007-10-19 2009-04-23 The Regents Of The University Of California Use of biomarkers of alzheimer's disease for diagnostic tests and drug screening
US7771957B2 (en) * 2007-10-19 2010-08-10 The Regents Of The University Of California Method for diagnosing alzheimer's disease
AT506535B1 (de) 2008-02-22 2010-04-15 Affiris Forschungs & Entwicklungs Gmbh Vaccine enthaltend alpha-synuclein-mimotope auf basis von peptiden
WO2009149487A2 (en) 2008-06-12 2009-12-17 Affiris Ag Compounds for treating symptoms associated with parkinson's disease
AT506819B1 (de) 2008-06-12 2011-06-15 Affiris Forschungs Und Entwicklungs Gmbh Vakzin zur behandlung von alzheimer-krankheit
AT509611B1 (de) 2008-06-12 2012-04-15 Affiris Forschungs-Und Entwicklungs Gmbh Vakzin
EP2401617A4 (en) * 2009-02-24 2012-09-26 Winton G Gibbons DETECTION OF COMPLEXES FORMED BETWEEN THE TAU PROTEIN AND AN AMYLOID
WO2010128139A1 (en) 2009-05-08 2010-11-11 Georg-August-Universität Göttingen Stiftung Öffentlichen Rechts, Universitätsmedizin Biomarkers and methods for diagnosing alzheimer's disease and/ or mild cognitive impairment
AT508638B1 (de) 2009-08-21 2011-08-15 Affiris Ag Verwendung von peptiden und polypeptiden zur behandlung und/oder prävention von synukleinopathien
WO2011106732A1 (en) * 2010-02-25 2011-09-01 Wyeth Llc Pet monitoring of ab-directed immunotherapy

Also Published As

Publication number Publication date
EP2579042A1 (en) 2013-04-10
DK2764367T3 (da) 2018-10-29
RU2014117677A (ru) 2015-11-10
US9625459B2 (en) 2017-04-18
KR20140069346A (ko) 2014-06-09
PL2764367T3 (pl) 2019-04-30
US20140242727A1 (en) 2014-08-28
WO2013050248A1 (en) 2013-04-11
CN103842825A (zh) 2014-06-04
WO2013050249A1 (en) 2013-04-11
HRP20140937T1 (hr) 2014-12-05
PL2579042T3 (pl) 2014-12-31
SG11201400223SA (en) 2014-05-29
CA2850840A1 (en) 2013-04-11
BR112014008088A2 (pt) 2017-04-18
MX2014003984A (es) 2014-05-07
CA2850843A1 (en) 2013-04-11
SG11201400229XA (en) 2014-05-29
IL231620A0 (en) 2014-05-28
ES2496341T3 (es) 2014-09-18
EP2764367A1 (en) 2014-08-13
AU2012320766A1 (en) 2014-03-13
AR088108A1 (es) 2014-05-07
EP2764368A1 (en) 2014-08-13
CN103842825B (zh) 2016-04-20
BR112014008089A2 (pt) 2017-04-18
CY1115624T1 (el) 2017-01-04
HK1178601A1 (en) 2013-09-13
MX2014003983A (es) 2014-05-07
EP2579042B1 (en) 2014-07-09
JP2014529088A (ja) 2014-10-30
JP6162127B2 (ja) 2017-07-12
ES2692185T3 (es) 2018-11-30
KR20140073568A (ko) 2014-06-16
SMT201400145B (it) 2014-11-10
CN103842824A (zh) 2014-06-04
US20140234877A1 (en) 2014-08-21
PT2579042E (pt) 2014-09-09
AU2012320766B2 (en) 2017-09-21
IL231057A0 (en) 2014-03-31
AU2012320767A1 (en) 2014-03-13
EP2764367B1 (en) 2018-07-25
JP2014529087A (ja) 2014-10-30
SI2579042T1 (sl) 2014-09-30
RU2014117671A (ru) 2015-11-10
RS53496B1 (sr) 2015-02-27

Similar Documents

Publication Publication Date Title
DK2723884T4 (da) Fremgangsmåde til påvisning af tilstedeværelsen af carbapenemase-producerende bakterier i en prøve
IL238408B (en) Method of detecting a microvesicle population in a biological sample
SG11201400229XA (en) METHOD FOR DETECTING Aß-SPECIFIC ANTIBODIES IN A BIOLOGICAL SAMPLE
EP3425063C0 (en) Methods for analyte detection
ZA201401130B (en) Methods and systems for detecting an analyte in a sample
ZA201405506B (en) Methods and systems for detecting a pathogen in a biological sample
IL231872A0 (en) Method and system for analyzing biological specimens by spectral imaging
EP2684057A4 (en) CARTRIDGE-BASED SYSTEM AND METHOD FOR DETECTING ANALYTE IN A SAMPLE
ITRM20120383A1 (it) Metodo e kit per la rivelazione di anticorpi.
DK3502125T3 (da) Peptider og fremgangsmåder til detektering af LYME-sygdomsantifstoffer
EP2666101A4 (en) METHOD AND SYSTEM FOR SELECTION OF RESPONDER
DK2689251T3 (da) Fremgangsmåde til detektering og kvantificering af et målmolekyle i en prøve
DK2732260T3 (da) Prøveopsamlingskit
EP2770329A4 (en) AUTOMATED ANALYZER
DK2936118T3 (da) Apparat til detektering af koncentrationen af en bestanddel i en prøve
GB201115120D0 (en) Method and device for detecting an analyte
BR112013019162A2 (pt) método de análise e dispositivo de leitura de microarranjo
PT2564202E (pt) Métodos de deteção de anticorpos
BR112014012045A2 (pt) métodos para detectar analito em amostra e para detectar um patógeno em um ferimento em um indivíduo
EP2691544A4 (en) METHOD FOR TESTING BIOASSAY SAMPLES
EP2690444A4 (en) SAMPLE ANALYSIS DEVICE
BRPI1015445A2 (pt) método para detecção de uma substância em amostra biológica
BR112013022539A2 (pt) dispositivo receptor, método de recepção, e, programa
GB201322538D0 (en) Method for detecting small molecules in a sample
IL215322A0 (en) Method for detecting antibody against sith-1 in biological sample